AQR Capital Management - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$473,000
+1.1%
17,355
-0.3%
0.00%
Q2 2018$468,000
-15.5%
17,4110.0%0.00%
-100.0%
Q1 2018$554,000
+15.2%
17,411
+37.0%
0.00%0.0%
Q4 2017$481,000
-34.6%
12,713
-57.2%
0.00%0.0%
Q3 2017$736,000
+153.8%
29,678
+110.5%
0.00%
Q2 2017$290,00014,0960.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders